Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Pain 3Neuralgia 3Breast Neoplasms 3Seizures 1Pinealoma 1Oligodendroglioma 1Obesity 1Neuroectodermal Tumors, Primitive 1Neoplasms 1Myotoxicity 1Meningioma 1Medulloblastoma 1Lymphoma 1Inflammation 1Head and Neck Neoplasms 1Gliosarcoma 1Glioma 1Glioblastoma 1Ependymoma 1Earache 1Drug-Related Side Effects and Adverse Reactions 1Central Nervous System Neoplasms 1Brain Neoplasms 1Astrocytoma 1Agnosia 1

Interventions

Temozolomide 2Sirolimus 2Irinotecan 2Bevacizumab 2tozuleristide 1etoposide phosphate 1Stem Cell Transplantation 1Pregabalin 1Nivolumab 1Mental Status and Dementia Tests 1Magnetic Resonance Spectroscopy 1Levetiracetam 1Immunoglobulin G 1Ginkgo biloba extract 1Etoposide 1Donepezil 1Disulfides 1Dasatinib 1Cyclophosphamide 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Pinealoma × Pregabalin × Clear all
NCT00629889 2013-05-22

Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors

Centre Hospitalier Universitaire Vaudois

Phase 2 Completed
52 enrolled
CNSSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Oligodendroglioma, Pinealoma, Seizures, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡